Table of Contents
Cervical cancer has contributed to increased mortality and morbidity rates among women in most of the developing countries. Healthcare provision has been hindered by various factors such as socioeconomic, age, developmental and cultural factors. Quality healthcare service determines various aspects of clinical outcomes hence dynamic analysis and diagnosis.
- Excellent quality
- 100% Turnitin-safe
- Affordable prices
Developmental factors involve analyzing symptoms and changes encountered by the patient. Socio-economic factors determine the ability of the patient to access treatment based on his or her financial capabilities (Peccatori, Et al., 2013). Cultural factors refrain different groups of people from accessing treatment due to generalized beliefs of the disease and the existence of traditional remedies and herbal practices that are evidenced in various parts of the world (Kingham, et al, 2013). The age is one of the risk factors among the cervical cancer patients. Patients above the age of 35 years are more vulnerable to the condition compared to individuals of a younger age (Peccatori, Et al., 2013). Such factors would enable effective assessment in gathering information from the patient. Therefore, addressing socioeconomic, cultural and developmental issues would aid in the development of viable models of cervical cancer care in the resource-limited countries.
The information on appearance, behavior, cognition and thought have been provided. The patient shows fear of the examination outcomes, she trembles, and panics due to the family historical case where her mother had died of cervical cancer. Before diagnosis is conducted the patient should explain if she has experienced other health conditions such as hepatitis B or HIV/AIDS. Furthermore, a brief explanation of any reproductive health information would be helpful in conducting diagnosis (Kingham, et al, 2013).
Healthcare provision on cervical cancer has improved. With gynecologic medical measures put in place, the mortality and morbidity rates have reduced. However, access to quality healthcare in developing countries has continued to be a challenge.
- Kingham, T. P., Alatise, O. I., Vanderpuye, V., Casper, C., Abantanga, F. A., Kamara, T. B., … & Denny, L. (2013). Treatment of cancer in sub-Saharan Africa. The Lancet Oncology, 14(4), e158-e167.
- Peccatori, F. A., Azim Jr, H. A., Orecchia, R., Hoekstra, H. J., Pavlidis, N., Kesic, V., … & ESMO Guidelines Working Group. (2013). Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 24(suppl_6), vi160-vi170.